Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

YL-939 is an inhibitor of ferroptosis.1 It inhibits erastin-induced increases in ferrous iron levels and ferroptosis in ES-2 ovarian cancer cells when used at a concentration of 0.3 µM. YL-939 (10 µM) increases nuclear receptor coactivator 4 (NCOA4) and ferritin levels in ES-2 cells. In vivo, YL-939 (3 mg/kg) decreases serum alanine transaminase (Alt) and aspartate aminotransferase (Ast) levels, reduces liver and serum malondialdehyde (MDA) levels, and increases liver ferritin levels in a mouse model of acetaminophen-induced acute liver injury.
WARNING This product is not for human or veterinary use.
1. Non-